{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/16422058",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1073612076"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#16422058",
  "code": "XH0L58",
  "source": "http://id.who.int/icd/entity/16422058",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Therapy-related myelodysplastic syndrome, NOS"
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Therapy-related myelodysplastic syndrome, alkylating agent related"
      }
    }
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Therapy-related myelodysplastic syndrome, NOS"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Therapy-related myelodysplastic syndrome, alkylating agent related"
      }
    }
  ]
}